Organization | Field Name | ID | Required |
|---|---|---|---|
KCR | Type of First Recurrence (RecurStatus) | 31790 | yes |
NAACCR | Recurrence Type--1st | yes |
Field Length: 2
This item identifies the type of first recurrence after a period of documented disease-free intermission or remission.
Instructions for Coding
Code the type of first recurrence. First recurrence may occur well after completion of the first course of treatment or after subsequent treatment.
If the patient has never been disease-free (code 70), continue to track for disease-free status. This may occur after subsequent treatment has been completed.
If the patient is disease-free (code 00), continue to track until a recurrence occurs. First recurrence may occur well after completion of the first course of treatment.
Once a recurrence has been recorded (code 04-62 or 88), subsequent recurrences are NOT to be recorded.
Codes 00 through 70 are hierarchical. Record the highest numbered applicable response.
If the tumor was originally diagnosed as in situ, code recurrence to 06, 16, 17, 26, 27, 36, or 46 only. Do not use those codes for any other tumors. Codes 00, 88, or 99 may apply to any tumor.
Codes 51-59 (organ or organ system of distant recurrence) apply only if all first occurrences were in a single category. There may be multiple metastases (or "seeding") within the distant location.
Code lymphomas or leukemias that are in remission 00. If the patient relapses, then code recurrence status as 59. If one of these is controlled by drugs (for example Gleevec for CML), the patient is in remission.
If there is more than one primary tumor and the physician is unable to decide which has recurred, code the recurrent disease for each tumor. If, at a later date, the recurrent primary is identified, revise the codes as appropriate.
Code | Description |
|---|---|
00 | Patient became disease-free after treatment and has not had a recurrence |
04 | In situ recurrence of an invasive tumor |
06 | In situ recurrence of an in-situ tumor |
10 | Local recurrence, NOS |
13 | Local recurrence of an invasive tumor |
14 | Trocar recurrence of an invasive tumor |
15 | Combination of 13 and 14 |
16 | Local recurrence of an in situ tumor |
17 | Both local and trocar recurrence of an in situ tumor |
20 | Regional, NOS |
21 | Recurrence of an invasive tumor in adjacent tissue or organ(s) only |
22 | Recurrence of an invasive tumor in regional lymph nodes only |
25 | Combination of 21 and 22 |
26 | Regional recurrence of an in situ tumor |
27 | Combination of 26 with 21, 22 and/or 25 |
30 | Any combination of 10-15 and 20-25 |
36 | Any combination of 16-17 and 26-27 |
40 | Distant recurrence, NOS |
46 | Distant recurrence of an in situ tumor |
51 | Distant recurrence of an invasive tumor in the peritoneum only. Peritoneum includes peritoneal surfaces of all structures within the abdominal cavity and/or positive ascitic fluid |
52 | Distant recurrence of an invasive tumor in the lung only. Lung includes the visceral pleura |
53 | Distant recurrence of an invasive tumor in the pleura only. Pleura includes the pleural surface of all structures within the thoracic cavity and/or positive pleural fluid |
54 | Distant recurrence of an invasive tumor in the liver only |
55 | Distant recurrence of an invasive tumor in bone only. This includes bones other than the primary site |
56 | Distant recurrence of an invasive tumor in the CNS only. This includes the brain and spinal cord, but not the external eye |
57 | Distant recurrence of an invasive tumor in the skin only. This includes skin other than the primary site |
58 | Distant recurrence of an invasive tumor in lymph node only. Refer to the staging scheme for a description of lymph nodes that are distant for a particular site |
59 | Distant systemic recurrence of an invasive tumor only. This includes lymphoma, leukemia, bone marrow metastasis, carcinomatosis, generalized disease |
60 | Distant recurrence of an invasive tumor in a single distant site (51-58) and local, trocar and/or regional recurrence (10-15, 20-25, or 30) |
62 | Distant recurrence of an invasive tumor in multiple sites (recurrences that can be coded to more than one category 51-59) |
70 | Since diagnosis, patient has never been disease-free |
88 | Recurred, site unknown |
99 | It is unknown whether the disease has recurred or if the patient was ever disease-free |